Page last updated: 2024-11-02

oxidopamine and Anterior Choroidal Artery Infarction

oxidopamine has been researched along with Anterior Choroidal Artery Infarction in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Chang, CF1
Morales, M1
Chiang, YH1
Harvey, BK1
Su, TP1
Tsao, LI1
Chen, S1
Thiemermann, C1
Buisson, A1
Callebert, J1
Mathieu, E1
Plotkine, M1
Boulu, RG1

Other Studies

2 other studies available for oxidopamine and Anterior Choroidal Artery Infarction

ArticleYear
Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Aug-27, Volume: 23, Issue:21

    Topics: Animals; Apoptosis; Blood Pressure; Brain Ischemia; Cell Hypoxia; Cells, Cultured; Cerebral Cortex;

2003
Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia.
    Journal of neurochemistry, 1992, Volume: 59, Issue:3

    Topics: Animals; Aspartic Acid; Brain Ischemia; Cerebral Infarction; Corpus Striatum; Dopamine; Extracellula

1992